$1.41
-0.05-3.42%
Last update: Nov 5, 4:02 PM
Enveric Biosciences Inc
ENVBNASDAQ
The average analyst price target for Enveric Biosciences is $120, 8533.1% above the current price. The one analyst covering it rates it Buy. The latest change came on Jan 30, 2024, when HC Wainwright & Co. initiated coverage of Enveric Biosciences with a Buy rating and a $1,800 price target.
Price Target Range — 2 Quarters
Analyst Consensus — 1 Analysts
Rating Trend — Last 9 Months
